Logo
Home
Archive
Tools & Resources
About
Search
Login
Sign Up
Logo

Archive

Missed a briefing? Here you can find all our past issues.

TOP 10

10 important lessons you should learn about AI x bio in 2026

Jun 9, 2026

•

9 min read

10 important lessons you should learn about AI x bio in 2026

What 150 stories reveal about the bottlenecks, breakthroughs and next questions in the field.

Peter Ottsjö
Peter Ottsjö
Why Lila may raise $2B - for “scientific superintelligence”

Jun 8, 2026

•

8 min read

Why Lila may raise $2B - for “scientific superintelligence”

Plus: Pfizer adds Chai, Nature takes stock of virtual cells, Claude tries chemistry, and AI leaders call for DNA screening.

Peter Ottsjö
Peter Ottsjö
NewLimit raises $435M for aging reprogramming

Jun 3, 2026

•

6 min read

NewLimit raises $435M for aging reprogramming

Plus: an AI reads tumor genomes as a whole, Waypoint Bio moves cell therapies toward the clinic, and bio agents go back to school.

Peter Ottsjö
Peter Ottsjö
Drug delivery is broken. This group has a plan to fix that.

May 31, 2026

•

6 min read

Drug delivery is broken. This group has a plan to fix that.

Plus: OpenAI turns Rosalind toward biodefense, AI maps cancer’s immune neighborhoods, and AI scientists learn to organize themselves.

Peter Ottsjö
Peter Ottsjö

TOP 10

The TOP 10 AI x bio stories in May

May 29, 2026

•

5 min read

The TOP 10 AI x bio stories in May

World models for proteins, robot hands in the wet lab, AI scientists in Nature, and safety filters that still cannot tell ordinary biology from risky biology.

Peter Ottsjö
Peter Ottsjö
Here's what we know about Biohub's world model for proteins

May 28, 2026

•

7 min read

Here's what we know about Biohub's world model for proteins

Plus: AI makes prime editing less fragile, Claude gets biosecurity-tested, and Insilico creates a longevity model.

Peter Ottsjö
Peter Ottsjö
Retro raises at $1.8B to move aging biology into the clinic

May 24, 2026

•

4 min read

Retro raises at $1.8B to move aging biology into the clinic

Plus: Incyte feeds Genesis its data, and AI designs RNA pseudoknots - without an AlphaFold moment.

Peter Ottsjö
Peter Ottsjö
Now it’s undeniable: AI scientists are here

May 21, 2026

•

9 min read

Now it’s undeniable: AI scientists are here

Plus: MouseMapper’s AI maps disease across the whole body, Hugging Face opens a faster DNA model, and Genentech gives virtual cells a tougher test.

Peter Ottsjö
Peter Ottsjö
“No virtual cell model actually uses AlphaFold”

May 16, 2026

•

9 min read

“No virtual cell model actually uses AlphaFold”

Plus: Morgan Levine on the wrong AI for aging, AI agents tie humans at protein design, and Isomorphic raises $2.1B.

Peter Ottsjö
Peter Ottsjö
Making sense of Isomorphic’s $2B raise

May 11, 2026

•

5 min read

Making sense of Isomorphic’s $2B raise

Plus: Young AI talent shuns pharma, DeepMind’s AlphaEvolve reaches genomics, and Kanvas maps the microbiome.

Peter Ottsjö
Peter Ottsjö
Load more

BAIO

The biggest tech story of the century.